FeesSafety
Pluang+

Rocket Lab shares at $57 offer 62% upside as growth and contracts boost 2027 outlook.

Analyst Insights
17 Nov 2026, 14:15 WIB
24/7 Wall Street
View Source
Bullish
Rocket Lab shares at $57 offer 62% upside as growth and contracts boost 2027 outlook.

Rocket Lab's stock, currently down 17.76% year-to-date at $57, is seen by analysts as a strong buy with a 62% upside potential to around $93. Revenue is expected to grow 37% from $980 million in 2026 to $1.34 billion in 2027, supported by a record $3.57 billion backlog and key contracts like the $816 million SDA deal. The upcoming Neutron rocket launches, Iridium acquisition, and higher launch prices are key catalysts that could push the stock to $100 in 2027, despite current losses and risks like dilution and launch delays.

Rocket Lab's stock trades at $57.92 on Pluang as of Nov 17, 2026, showing a 0.96% gain in the last day. The stock's market cap stands at $38.61 billion, with a 52-week trading range between $39.48 and $150.23. Pluang users currently lean slightly towards selling, with 59% of orders as of the same date.

More News (RKLB)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App